Prashant Sinha

Prashant Sinha

Auto-generated profile, based on publicly available information

Prashant Sinha

NYU Langone Medical Center

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2009 in Journal of Gastrointestinal Surgery
Verified
Journal Article
Closed access
PDF file
Andrew A. GumbsAndrew A. Gumbs
Andrew A. Gumbs
LMLuca Milone
Luca Milone
PSPrashant Sinha
Prashant Sinha
MBMarc Bessler
Marc Bessler

1 January 2008 in Thyroid®
Verified
Journal Article
Closed access
WIWilliam B. Inabnet
William B. Inabnet
ASAlexander Shifrin
Alexander Shifrin
LALeaque Ahmed
Leaque Ahmed
PSPrashant Sinha
Prashant Sinha
The thyroid gland is one of the most vascular organs in the body and surgical resection mandates meticulous surgical technique and hemostasis. The aim of this study was to assess the safety and efficacy of the electrothermal bipolar vessel sealing system in permitting ambulatory thyroid surgery under local anesthesia. From January 1, 2004, to December 31, 2005, 224 consecutive patients underwent thyroid surgery using the LigaSure for hemostasis. Whenever possible, local/regional anesthesia with conscious sedation was utilized during the procedure. A descriptive analysis was performed to evaluate patient characteristics and outcome measures. Eighty-two percent (n = 184) of all unselected patients presenting for thyroid surgery had their procedure performed under local/regional anesthesia with conscious sedation whereas 18% (n = 40) received general anesthesia. When comparing these two groups, the local anesthesia patients were more likely to be female (85% vs. 68%, p < or = 0.05) and younger (mean age = 50 vs. 61 years, p < or= 0.05). Forty percent of the local anesthesia patients underwent a total thyroidectomy compared to 58% in the general anesthesia group (p < or = 0.05). The mean duration of surgery was shorter in the local anesthesia patients (71 minutes vs. 101 minutes, p < or = 0.05) and the mean gland weight was also less (26.9 g vs. 63.9 g, p < or = 0.05). There was one hematoma in the local anesthesia group, but overall the morbidity was not different. Eighty-eight percent of the local anesthesia patients were discharged same day of surgery compared to 45% of the general anesthesia patients. The electrothermal bipolar vessel sealing system permits safe, same day discharge in patients undergoing thyroid surgery with a low complication rate irrespective of the type of anesthesia.

1 August 2001 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
RJRanjit John
Ranjit John
HRHiranya A Rajasinghe
Hiranya A Rajasinghe
JCJonathan M Chen
Jonathan M Chen
AWAlan D Weinberg
Alan D Weinberg
PSPrashant Sinha
Prashant Sinha
NENiloo M Edwards
Niloo M Edwards

1 September 2000 in Annals of Surgery
Verified
Journal Article
Closed access
RJRanjit John
Ranjit John
HRHiranya Rajasinghe
Hiranya Rajasinghe
JCJonathan M. Chen
Jonathan M. Chen
AWAlan D. Weinberg
Alan D. Weinberg
PSPrashant Sinha
Prashant Sinha
NENiloo M. Edwards
Niloo M. Edwards
To study risk factors for early and late death after heart transplantation in the current era. The current cardiac transplant population differs from earlier periods in that an increasing number of sicker patients, such as those with ventricular assist device (LVAD) support, prior cardiac allotransplantation, and pulmonary hypertension, are undergoing transplantation. In addition, sensitized patients constitute a greater proportion of the transplanted population. Emphasis has been placed on therapies to prevent early graft loss, such as the use of nitric oxide and improved immunosuppression, in addition to newer therapies. Five hundred thirty-six patients undergoing heart transplantation between 1993 and 1999 at a single center were evaluated (464 adults and 72 children; 109 had received prior LVAD support and 24 underwent retransplantation). The mean patient age at transplantation was 44.9 years. Logistic regression and Cox proportional hazard models were used to evaluate the following risk factors on survival: donor and recipient demographics, ischemic time, LVAD, retransplantation, pretransplant pulmonary vascular resistance, and immunologic variables (ABO, HLA matching, and pretransplant anti-HLA antibodies). The rate of early death (less than 30 days) was 8.5% in adults and 8.8% in children. The actuarial survival rate of the 536 patients was 83%, 77%, and 71% at 1, 3, and 5 years, respectively, by Kaplan Meier analysis. Risk factors adversely affecting survival included the year of transplant, donor age, and donor-recipient gender mismatching. Neither early nor late death was influenced by elevated pulmonary vascular resistance, sensitization, prior LVAD support, or prior cardiac allotransplantation. Previously identified risk factors did not adversely affect short- or long-term survival of heart transplant recipients in the current era. The steady improvement in survival during this period argues that advances in transplantation have offset the increasing acuity of transplant recipients.

1 May 2003 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Closed access
MKMinoo N Kavarana
Minoo N Kavarana
PSPrashant Sinha
Prashant Sinha
YNYoshifumi Naka
Yoshifumi Naka
MOMehmet C Oz
Mehmet C Oz
NENiloo M Edwards
Niloo M Edwards

25 April 2008 in Surgical Endoscopy
Verified
Journal Article
Closed access
PDF file
PSPrashant Sinha
Prashant Sinha
NHNancy J. Hogle
Nancy J. Hogle
DFDennis L. Fowler
Dennis L. Fowler